{Reference Type}: Journal Article
{Title}: A pilot study of virtual reality for inpatients with opioid use disorder.
{Author}: Greenwald HJ;Berger A;Wilson RLH;Greenwald DJ;Lannon E;Johnson-Smith P;Bergman BG;Wilens TE;
{Journal}: Am J Addict
{Volume}: 33
{Issue}: 4
{Year}: 2024 07 2
{Factor}: 3.86
{DOI}: 10.1111/ajad.13526
{Abstract}: While inpatient withdrawal management/acute stabilization can improve outcomes for individuals with opioid use disorder (OUD), patients often leave treatment early due to mood, tension, and cravings associated with opioid withdrawal. The aim of this study was to evaluate the feasibility and preliminary effectiveness of a novel virtual reality (VR) based intervention; 3D Therapy Thrive (3DTT).
Subjects with OUD (Nā=ā32) were recruited from a community acute stabilization program and received up to two sessions of 3DTT. They completed questionnaires related to their overall satisfaction with the experience and side effects; as well as those related to mood, tension, and cravings.
There were no reported side effects and the majority of subjects (94%) reported high satisfaction with the experience. Out of 62 patients approached, 33 patients agreed to participate (53%) 33 patients completed one, and 17 of these patients (52%) completed both sessions of 3DTT, with 19 participants (58%) completing their treatment protocols. Compared to baseline, 3DTT participants reported significant reductions in depression, tension, and cravings (p'sā<ā0.001).
This pilot study supports the feasibility and preliminary effectiveness of 3DTT for improving outcomes for inpatients with OUD. Future randomized controlled trials are necessary to evaluate the efficacy of 3DTT for improving retention, reducing cravings, and improving mood and tension.
This is the first study to evaluate the feasibility of a psychologically informed VR intervention in inpatients with OUD.